Roshanak Shams

492 total citations
35 papers, 369 citations indexed

About

Roshanak Shams is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Roshanak Shams has authored 35 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Roshanak Shams's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Immunotherapy and Immune Responses (5 papers). Roshanak Shams is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Immunotherapy and Immune Responses (5 papers). Roshanak Shams collaborates with scholars based in Iran, Sweden and India. Roshanak Shams's co-authors include Soudeh Ghafouri‐Fard, Ali Behmanesh, Amir Sadeghi, Mohammad Reza Zali, Reza Mirfakhraie, Mir Davood Omrani, Samaneh Saberi, Hamid Asadzadeh Aghdaei, Azadeh Bashiri and Mohammad Taheri and has published in prestigious journals such as Scientific Reports, BMC Public Health and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Roshanak Shams

34 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roshanak Shams Iran 11 224 177 92 64 29 35 369
Yuwen Cao China 10 272 1.2× 130 0.7× 102 1.1× 68 1.1× 40 1.4× 23 428
Guangdong Qiao China 9 105 0.5× 84 0.5× 97 1.1× 95 1.5× 40 1.4× 31 264
Wenbo Zheng China 11 189 0.8× 196 1.1× 104 1.1× 16 0.3× 47 1.6× 21 338
Panagiotis Chouvardas Switzerland 12 189 0.8× 85 0.5× 88 1.0× 88 1.4× 39 1.3× 28 361
Jiangdong Qiu China 13 168 0.8× 138 0.8× 187 2.0× 62 1.0× 49 1.7× 32 365
Paola Dama United Kingdom 9 223 1.0× 123 0.7× 180 2.0× 118 1.8× 21 0.7× 18 448
Yeon Hyang Kim South Korea 9 211 0.9× 124 0.7× 51 0.6× 99 1.5× 16 0.6× 24 356
Christian H. Bergsland Norway 10 127 0.6× 65 0.4× 153 1.7× 81 1.3× 62 2.1× 14 299
Rong Guo China 10 274 1.2× 290 1.6× 103 1.1× 22 0.3× 50 1.7× 37 478

Countries citing papers authored by Roshanak Shams

Since Specialization
Citations

This map shows the geographic impact of Roshanak Shams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roshanak Shams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roshanak Shams more than expected).

Fields of papers citing papers by Roshanak Shams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roshanak Shams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roshanak Shams. The network helps show where Roshanak Shams may publish in the future.

Co-authorship network of co-authors of Roshanak Shams

This figure shows the co-authorship network connecting the top 25 collaborators of Roshanak Shams. A scholar is included among the top collaborators of Roshanak Shams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roshanak Shams. Roshanak Shams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qaderi, Kowsar, et al.. (2025). Artificial intelligence (AI) approaches to male infertility in IVF: a mapping review. European journal of medical research. 30(1). 246–246. 1 indexed citations
3.
Behmanesh, Ali, et al.. (2024). Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167357–167357. 2 indexed citations
4.
Bagherifard, Abolfazl, et al.. (2024). Exploring circulating MiRNA signature for osteosarcoma detection: Bioinformatics-based analyzing and validation. Pathology - Research and Practice. 263. 155615–155615. 2 indexed citations
5.
Rastad, Hadith, et al.. (2023). Clinicopathological and prognostic value of lncRNA TPT1-AS1 in cancer: A systematic review study and meta-analysis. Pathology - Research and Practice. 245. 154403–154403. 1 indexed citations
6.
Garavand, Ali, et al.. (2023). Telemedicine in cancer care during COVID-19 pandemic: a systematic mapping study. Health and Technology. 13(4). 665–678. 8 indexed citations
7.
Shams, Roshanak, Ali Behmanesh, Nikoo Hossein‐Khannazer, et al.. (2023). Developed Bone Biomaterials Incorporated with MicroRNAs to Promote Bone Regeneration: A Systematic Review, Bioinformatics, and Meta-analysis Study. ACS Biomaterials Science & Engineering. 9(9). 5186–5204. 7 indexed citations
8.
Ghafouri‐Fard, Soudeh, et al.. (2022). Evaluation of potential of miR-8073 and miR-642 as diagnostic markers in pancreatic cancer. Molecular Biology Reports. 49(7). 6475–6481. 5 indexed citations
9.
Garavand, Ali, Nasim Aslani, Ali Behmanesh, & Roshanak Shams. (2022). Telemedicine in lung cancer during COVID-19 outbreak. Journal of Education and Health Promotion. 11(1). 348–348. 6 indexed citations
10.
Soltani, Farhad, et al.. (2022). Four decades of hand microsurgery in Iran. Journal of Education and Health Promotion. 11(1). 418–418. 1 indexed citations
12.
Shams, Roshanak, Samaneh Saberi, Mohammad Reza Zali, et al.. (2020). Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods. Scientific Reports. 10(1). 7559–7559. 46 indexed citations
13.
Noroozi, Rezvan, et al.. (2019). Genetic variants within Ninjurin 2 gene are associated with risk of ischemic stroke in Iranian population. Neurological Sciences. 40(12). 2603–2607. 7 indexed citations
14.
Shams, Roshanak, et al.. (2019). Expression analysis of miR-100 and selected genes from mTOR pathway in breast cancer patients. Meta Gene. 21. 100577–100577. 1 indexed citations
15.
Geranpayeh, Lobat, et al.. (2018). Expression analysis of CBR3-AS1 and androgen receptor genes in breast cancer. Meta Gene. 17. 82–87. 1 indexed citations
16.
Shams, Roshanak, et al.. (2018). Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues. Cancer Management and Research. Volume 10. 1969–1974. 22 indexed citations
17.
Shams, Roshanak, et al.. (2018). Application of Cancer-Testis Antigens in Immunotherapy of Hepatocellular Carcinoma. Immunotherapy. 10(5). 411–421. 11 indexed citations
18.
Ghafouri‐Fard, Soudeh, et al.. (2015). Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens. Iranian Journal of Cancer Prevention. 8(5). e3755–e3755. 12 indexed citations
19.
Ghafouri‐Fard, Soudeh, et al.. (2014). Cancer–Testis Genes as Candidates for Immunotherapy in Breast Cancer. Immunotherapy. 6(2). 165–179. 40 indexed citations
20.
Shams, Roshanak, Soudeh Ghafouri‐Fard, Reza Mirfakhraie, et al.. (2013). Expression Analysis of Two Cancer-testis Genes, FBXO39 and TDRD4, in Breast Cancer Tissues and Cell Lines. Asian Pacific Journal of Cancer Prevention. 14(11). 6625–6629. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026